Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Revenue
€ 5.1 million
Profit
Caution€ -5.3 million
▲ 10% vs 2024
Debts
Low€ 2.7 million
▼ 61% vs 2024
Hyloris Developments from Liège, company number BE0542737368, closed financial year 2025 with a result of € -5.3 million after tax. For that financial year Hyloris Developments recorded revenue of € 5.1 million and equity of € 17.9 million. Compared with financial year 2024, the result moved from € -5.8 million to € -5.3 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
What happened at Hyloris Developments?
What happened at Hyloris Developments in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 5.3 million. Source: NBB ↗
- Jacobsen Management SRL stepped down as director. NBB
- SVR Management SRL stepped down as director. NBB
- Jacobsen Management SRL became a director. NBB
- SVR Management SRL became a director. NBB
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 2.6 million loss in 2021 to € 5.3 million loss in 2025.
On average € 447,200 of value added per employee in 2025.
A new publication or filing at Hyloris Developments? We notify you, reason included.
Follow Hyloris DevelopmentsNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by Thomas Jacobsen
Also active at: DERMAX, Hyloris, Hyloris Pharmaceuticals
since 2020 · until 2026
Managing director · represented by Van Rompay Stijn
Also active at: DERMAX, Hyloris, Hyloris Pharmaceuticals
since 2020 · until 2026
Establishments
Establishment units
Physical locations of this company
Boulevard de Patience et Beaujonc 3 box 1
4000 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 23 companies are registered at this address.
ONCORADIOMICS
€ 2.4 million gross margin · 2025
DERMAX same network
€ 1.6 million revenue · 2025
Hyloris same network
€ 384,852 revenue · 2025
Hyloris Pharmaceuticals same network
€ 3.8 million revenue · 2025
Hirundo Biosciences
€ 0 revenue · 2025
+18 more
Details
- Company number
- 0542.737.368
- VAT number
- BE 0542.737.368
- Registered office
- Boulevard de Patience et Beaujonc 3 bus 1, 4000 Liège
- Names & denominations
- Hyloris Developments
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 5 December 2013
- Peppol
- Active · Active since 21 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Vervaardiging van geneesmiddelen